Consumption of Fish and ?-3 Fatty Acids and Cancer Risk: An Umbrella Review of Meta-Analyses of Observational Studies.


Por: Lee KH, Seong HJ, Kim G, Jeong GH, Kim JY, Park H, Jung E, Kronbichler A, Eisenhut M, Stubbs B, Solmi M, Koyanagi A, Hong SH, Dragioti E, de Rezende LFM, Jacob L, Keum N, van der Vliet HJ, Cho E, Veronese N, Grosso G, Ogino S, Song M, Radua J, Jung SJ, Thompson T, Jackson SE, Smith L, Yang L, Hans Oh, Choi EK, Shin JI, Giovannucci EL and Gamerith G

Publicada: 1 sep 2020 Ahead of Print: 3 jun 2020
Resumen:
Multiple studies have suggested that ?-3 fatty acid intake may have a protective effect on cancer risk; however, its true association with cancer risk remains controversial. We performed an umbrella review of meta-analyses to summarize and evaluate the evidence for the association between ?-3 fatty acid intake and cancer outcomes. We searched PubMed, Embase, and the Cochrane Database of Systematic Reviews from inception to December 1, 2018. We included meta-analyses of observational studies that examined associations between intake of fish or ?-3 fatty acid and cancer risk (gastrointestinal, liver, breast, gynecologic, prostate, brain, lung, and skin) and determined the level of evidence of associations. In addition, we appraised the quality of the evidence of significant meta-analyses by using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. We initially screened 598 articles, and 15 articles, including 57 meta-analyses, were eligible. Among 57 meta-analyses, 15 reported statistically significant results. We found that 12 meta-analyses showed weak evidence of an association between ?-3 fatty acid intake and risk of the following types of cancer: liver cancer (n = 4 of 6), breast cancer (n = 3 of 14), prostate cancer (n = 3 of 11), and brain tumor (n = 2 of 2). In the other 3 meta-analyses, studies of endometrial cancer and skin cancer, there were no assessable data for determining the evidence levels. No meta-analysis showed convincing, highly suggestive, or suggestive evidence of an association. In the sensitivity analysis of meta-analyses by study design, we found weak associations between ?-3 fatty acid intake and breast cancer risk in cohort studies, but no statistically significant association in case-control studies. However, the opposite results were found in case of brain tumor risk. Although ?-3 fatty acids have been studied in several meta-analyses with regard to a wide range of cancer outcomes, only weak associations were identified in some cancer types, with several limitations. Considering the nonsignificant or weak evidence level, clinicians and researchers should cautiously interpret reported associations between ?-3 fatty acid consumption and cancer risks.

Filiaciones:
Lee KH:
 Department of Pediatrics, Yonsei University College of Medicine, Seoul, Republic of Korea

Seong HJ:
 Yonsei University College of Medicine, Seoul, Republic of Korea

Kim G:
 Keimyung University College of Nursing, Daegu, Republic of Korea

Jeong GH:
 College of Medicine, Gyeongsang National University, Jinju, Republic of Korea

Kim JY:
 Yonsei University College of Medicine, Seoul, Republic of Korea

Park H:
 Yonsei University Graduate School, Department of Nursing, Seoul, Republic of Korea

Jung E:
 Yonsei University Graduate School, Department of Nursing, Seoul, Republic of Korea

Kronbichler A:
 Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Innsbruck, Austria

Eisenhut M:
 Department of Pediatrics, Luton & Dunstable University Hospital NHS Foundation Trust, Luton, United Kingdom

Stubbs B:
 Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom

 South London and Maudsley NHS Foundation Trust, London, United Kingdom

 Faculty of Health, Social Care and Education, Anglia Ruskin University, Chelmsford, United Kingdom

Solmi M:
 Department of Neuroscience, University of Padova, Padova, Italy

Koyanagi A:
 Parc Sanitari Sant Joan de Déu/CIBERSAM, Universitat de Barcelona, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain

 ICREA, Barcelona, Spain

Hong SH:
 Yonsei University College of Medicine, Seoul, Republic of Korea

 Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, USA

Dragioti E:
 Pain and Rehabilitation Centre, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden

de Rezende LFM:
 Universidade Federal de São Paulo, Escola Paulista de Medicina, Departamento de Medicina Preventiva, São Paulo, São Paulo, Brazil

Jacob L:
 Parc Sanitari Sant Joan de Déu/CIBERSAM, Universitat de Barcelona, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain

 Faculty of Medicine, University of Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France

Keum N:
 Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA

 Department of Food Science and Biotechnology, Dongguk University, Goyang, Republic of Korea

van der Vliet HJ:
 Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, VU University, Amsterdam, The Netherlands

Cho E:
 Department of Dermatology, The Warren Alpert Medical School, Brown University, Providence, RI, USA

 Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA

Veronese N:
 National Research Council, Neuroscience Institute, Aging Branch, Padova, Italy

Grosso G:
 Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy

Ogino S:
 Cancer Immunology and Cancer Epidemiology Programs, Dana-Farber Harvard Cancer Center, Boston, MA, USA

 Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA

 Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA

 Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA

Song M:
 Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA

 Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA

 Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA

 Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA

Radua J:
 Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

 Mental Health Research Networking Center (CIBERSAM), Barcelona, Spain

 Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom

 Centre for Psychiatric Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

Jung SJ:
 Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA

 Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea

Thompson T:
 Department of Psychology, University of Greenwich, London, United Kingdom

Jackson SE:
 Department of Behavioral Science and Health, University College London, London, United Kingdom

Smith L:
 The Cambridge Centre for Sport and Exercise Sciences, Anglia Ruskin University, Chelmsford, United Kingdom

Yang L:
 Department of Cancer Epidemiology and Cancer Prevention, Alberta Health Services, Calgary, Canada

 Departments of Oncology and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada

Hans Oh:
 School of Social Work, University of Southern California, CA, USA

Choi EK:
 Mo-Im Kim Nursing Research Institute, Yonsei University College of Nursing, Seoul, Republic of Korea

Shin JI:
 Department of Pediatrics, Yonsei University College of Medicine, Seoul, Republic of Korea

Giovannucci EL:
 Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA

 Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA

Gamerith G:
 Internal Medicine V, Department of Hematology and Oncology, Medical University Innsbruck, Innsbruck, Austria
ISSN: 21618313





Advances in Nutrition
Editorial
ELSEVIER SCIENCE INC, STE 800, 230 PARK AVE, NEW YORK, NY 10169, Estados Unidos America
Tipo de documento: Article
Volumen: 11 Número: 5
Páginas: 1134-1149
WOS Id: 000592516100007
ID de PubMed: 32488249
imagen Green Accepted, Green Published, Bronze

MÉTRICAS